hypericin,
mono-(123I)iodohypericin,
hypericin,
548-04-9,
Hypericum red,
Cyclosan,
hipericina,
hypericine,
Hyperizin,
1,3,4,6,8,13-Hexahydroxy-10,11-dimethylphenanthro[1,10,9,8-opqra]perylene-7,14-dione,
Cyclo-Werol,
Hypericum Extract,
VIMRxyn,
UNII-7V2F1075HD,
C30H16O8,
EINECS 208-941-0,
MFCD00016683,
NSC407313,
Hypericin & Visible light,
NSC 407313,
NSC 622946,
(component of) Hypericum spp (st. John's wort),
7V2F1075HD,
NSC622946,
Cyclo werrol,
4,5,7,4',5',7'-Hexahydroxy-2,2'-dimethylnaphthodianthrone,
4,5,7,4',5',7'-Hexahydroxy-2,2'-dimethyl-mesonapthtodianthron,
1,3,4,6,8,13-Hexahydroxy-10,11-dimethylphenanthro(1,10,9,8-opqra)perylene-7,14-dione,
hexahydroxy(dimethyl)[?]dione,
Q-100618,
1:6:8:10:11:13-hexahydroxy-3:4-dimethyl-meso-naphthodianthrene-7:14-dione,
Phenanthro[1,10,9,8-opqra]perylene-7,14-dione, 1,3,4,6,8,13-hexahydroxy-10,11-dimethyl-,
Mycoporphyrin,
Vimr,
Cyclo-werrol,
CCRIS 8166,
Hypericin?,
BiomolKI_000032,
BiomolKI2_000040,
SCHEMBL3182,
BIDD:PXR0084,
BMK1-D8,
SCHEMBL10262695,
BIH1002,
DTXSID40203270,
BTXNYTINYBABQR-UHFFFAOYSA-N,
ZX-AFC000188,
Hypericin from Hypericum perforatum,
BCP10403,
HY-N0453,
ZINC3780340,
BDBM50060874,
CCG-36081,
CH-268,
GE3282,
HSCI1_000202,
LMPK13040001,
AKOS015895658,
AC-6048,
CS-5687,
DB13014,
EBD2048972,
MCULE-7319800130,
NSC-407313,
NSC-622946,
NCGC00162454-01,
NCGC00163378-01,
NCGC00163378-02,
4CN-1297,
AJ-45583,
AN-45822,
CC-29451,
NCI60_003879,
NCI60_006799,
SC-18495,
NCGC00163378-03!,
LS-175574,
FT-0627169,
N2739,
C07606,
33919-EP2275420A1,
33919-EP2295055A2,
33919-EP2295416A2,
33919-EP2298748A2,
33919-EP2298764A1,
33919-EP2298765A1,
33919-EP2305642A2,
33919-EP2311453A1,
548H049,
C-22963,
SR-05000002344,
Hypericin from Hypericum perforatum, ~95% (HPLC),
Hypericin, primary pharmaceutical reference standard,
SR-05000002344-2,
BRD-K29673530-001-03-9,
4,4',5,5',7,7'-Hexahydroxy-2,2'-dimethylnaphthodianthrone,
3,4,6,7,13,14-Hexahydroxy-10,11-dimethylphenanthro[1,10,9,8-opqra]perylene-1,8-dione,
3,4,7,8,13,14-Hexahydroxy-10,11-dimethylphenanthro[1,10,9,8-opqra]perylene-1,6-dione,
1,3,4,6,8,13-Hexahydroxy-10,11-dimethylphenanthro[1,10,9,8-opqra]perylene-7,14-dione, 9CI,
1,4,6,8,13-Hexahydroxy-10,11-dimethylphenanthro [1,10,9,8-opqra]perylene-7,14-dione P-conformer,
InChI=1/C30H16O8/c1-7-3-9(31)19-23-15(7)16-8(2)4-10(32)20-24(16)28-26-18(12(34)6-14(36)22(26)30(20)38)17-11(33)5-13(35)21(29(19)37)25(17)27(23)28/h3-6,31-36H,1-2H,
Phenanthro[1,10,9,8-opqra]perylene-7,14-dione,1,3,4,6,8,13-hexahydroxy-10,11-dimethyl-, stereoisomer,
Phenanthro[1,9,8-opqra]perylene-7,14-dione,1,3,4,6,8,13-hexahydroxy-10,11-dimethyl-, stereoisomer,
Hypericin, 98% 25mg,
mono-(123I)iodohypericin,
CHEBI:5835,
CHEMBL286494,
DRG-0113,
ACN-035464,
C30-H16-O8,
CID5281051,
C004965,
1,3,4,6,8,13-Hexahydroxy-10,11-dimethylphenanthro[1,10,9,8-opqra]perylene-7,14-dione stereoisomer,
Phenanthro(1,10,9,8-opqra)perylene-7,14-dione, 1,3,4,6,8,13-hexahydroxy-10,11-dimethyl-,
Phenanthro[1,10,9,8-opqra]perylene-7,14-dione, 1,3,4,6,8,13-hexahydroxy-10,11-dimethyl-, stereoisomer,